Evergreen NEET PG Preparation Update | Published 29 September 2026
No new NBEMS or MCC notice specific to the NEET PG 2026 cycle was identified during today’s official-source review. This is therefore a clearly labelled evergreen revision module, not an official examination notice.
Key points
- Five original single-best-answer questions.
- Answers stay hidden until the first attempt.
- Every answer includes the correct option and distractor explanations.
- Use the reset button to repeat the set.
Score: 0/5 · Attempted: 0/5
1. A patient taking amiodarone develops destructive thyroiditis. Which finding supports type 2 amiodarone-induced thyrotoxicosis?
2. Which antithyroid drug also inhibits peripheral conversion of T4 to T3 at high doses?
3. A newborn with congenital hypothyroidism should generally receive:
4. Painful thyroid enlargement after a viral illness with transient thyrotoxicosis suggests:
5. Which symptom requires urgent cessation and blood-count evaluation during carbimazole therapy?
Sources and limitations
Concepts are based on standard endocrine pharmacology and regulator-approved medicine information. Exact exam weightage and future NBEMS scheduling are uncertain. Always check the official NBEMS and MCC portals for notices.
Last reviewed: 29 September 2026
Educational disclaimer: This article is for professional education and public information. It does not replace individual diagnosis, prescription, emergency assessment or local institutional protocol.
यह लेख उपयोगी लगा? Share करें